Segueix
Douglas Lorne Arnold, MD, FRCP(C)
Douglas Lorne Arnold, MD, FRCP(C)
James McGill Professor: Department of Neurology and Neurosurgery, Faculty of Medicine, McGill
Correu electrònic verificat a mcgill.ca - Pàgina d'inici
Títol
Citada per
Citada per
Any
B-cell depletion with rituximab in relapsing–remitting multiple sclerosis
SL Hauser, E Waubant, DL Arnold, T Vollmer, J Antel, RJ Fox, A Bar-Or, ...
New England Journal of Medicine 358 (7), 676-688, 2008
24962008
Placebo-controlled phase 3 study of oral BG-12 for relapsing multiple sclerosis
R Gold, L Kappos, DL Arnold, A Bar-Or, G Giovannoni, K Selmaj, ...
New England Journal of Medicine 367 (12), 1098-1107, 2012
18122012
Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis
X Montalban, SL Hauser, L Kappos, DL Arnold, A Bar-Or, G Comi, ...
N Engl J Med 376 (3), 209-220, 2017
14742017
Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis
SL Hauser, A Bar-Or, G Comi, G Giovannoni, HP Hartung, B Hemmer, ...
N Engl J Med 376 (3), 221-234, 2017
13362017
Alemtuzumab for patients with relapsing multiple sclerosis after disease-modifying therapy: a randomised controlled phase 3 trial
AJ Coles, CL Twyman, DL Arnold, JA Cohen, C Confavreux, EJ Fox, ...
The lancet 380 (9856), 1829-1839, 2012
11252012
Alemtuzumab versus interferon beta 1a as first-line treatment for patients with relapsing-remitting multiple sclerosis: a randomised controlled phase 3 trial
JA Cohen, AJ Coles, DL Arnold, C Confavreux, EJ Fox, HP Hartung, ...
The Lancet 380 (9856), 1819-1828, 2012
11242012
Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study
Kappos L, Bar-Or A, Cree BAC, Fox RJ, Giovannoni G, Gold R, Vermersch P ...
Lancet 391 (10127), 1263-1273, 2018
6912018
Accurate, noninvasive diagnosis of human brain tumors by using proton magnetic resonance spectroscopy
MC Preul, Z Caramanos, DL Collins, JG Villemure, R Leblanc, A Olivier, ...
Nature medicine 2 (3), 1996
6451996
Evidence of axonal damage in the early stages of multiple sclerosis and its relevance to disability
N De Stefano, S Narayanan, GS Francis, R Arnaoutelis, MC Tartaglia, ...
Archives of neurology 58 (1), 65-70, 2001
6312001
Axonal damage correlates with disability in patients with relapsing-remitting multiple sclerosis: Results of a longitudinal magnetic resonance spectroscopy study
N De Stefano, PM Matthews, L Fu, S Narayanan, J Stanley, GS Francis, ...
Brain 121 (Pt 8), 1469-1477, 1998
5981998
Imaging axonal damage of normal-appearing white matter in multiple sclerosis
L Fu, PM Matthews, N De Stefano, KJ Worsley, S Narayanan, GS Francis, ...
Brain 121 (1), 103-113, 1998
5901998
Metabolic recovery after exercise and the assessment of mitochondrial function in vivo in human skeletal muscle by means of 31P NMR
DL Arnold, PM Matthews, GK Radda
Magnetic resonance in medicine 1 (3), 307-315, 1984
5581984
Rituximab in relapsing‐remitting multiple sclerosis: A 72‐week, open‐label, phase I trial
A Bar‐Or, PAJ Calabresi, D Arnold, C Markowitz, S Shafer, LH Kasper, ...
Annals of neurology 63 (3), 395-400, 2008
5512008
Mesial temporal damage in temporal lobe epilepsy: a volumetric MRI study of the hippocampus, amygdala and parahippocampal region
N Bernasconi, A Bernasconi, Z Caramanos, SB Antel, F Andermann, ...
Brain 126 (2), 462-469, 2003
5382003
Reversible decreases in N‐acetylaspartate after acute brain injury
ND Stefano, PM Matthews, DL Arnold
Magnetic Resonance in Medicine 34 (5), 721-727, 1995
5231995
Review of automatic segmentation methods of multiple sclerosis white matter lesions on conventional magnetic resonance imaging
D Garcia-Lorenzo, S Francis, S Narayanan, DL Arnold, DL Collins
Medical image analysis 17 (1), 1-18, 2013
4072013
Proton magnetic resonance spectroscopic imaging for metabolic characterization of demyelinating plaques
DL Arnold, PM Matthews, GS Francis, J O'Connor, JP Antel
Annals of Neurology: Official Journal of the American Neurological …, 1992
3961992
Energetics of human muscle: exercise-induced ATP depletion
DJ Taylor, P Styles, PM Matthews, DL Arnold, DG Gadian, P Bore, ...
Magn Reson Med 3 (1), 44-54, 1986
3901986
Pegylated interferon beta-1a for relapsing-remitting multiple sclerosis (ADVANCE): a randomised, phase 3, double-blind study
PA Calabresi, BC Kieseier, DL Arnold, LJ Balcer, A Boyko, J Pelletier, ...
The Lancet Neurology 13 (7), 657-665, 2014
3862014
Chemical pathology of acute demyelinating lesions and its correlation with disability
N De Stefano, PM Matthews, JP Antel, M Preul, G Francis, DL Arnold
Annals of neurology 38 (6), 901-909, 1995
3821995
En aquests moments el sistema no pot dur a terme l'operació. Torneu-ho a provar més tard.
Articles 1–20